NCT01665417 2017-02-08Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung AdenocarcinomaBetta Pharmaceuticals Co., Ltd.Phase 4 Unknown100 enrolled
NCT02103257 2015-04-29Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung AdenocarcinomaBetta Pharmaceuticals Co., Ltd.Phase 4 Unknown192 enrolled